dc.contributor.author |
Bernabé Ortiz, Antonio |
|
dc.contributor.author |
Sal Y Rosas, Víctor G. |
|
dc.contributor.author |
Ponce-Lucero, Vilarmina |
|
dc.contributor.author |
Cárdenas García-Santillán, María Kathia |
|
dc.contributor.author |
Carrillo Larco, Rodrigo Martín |
|
dc.contributor.author |
Diez-Canseco Montero, Francisco |
|
dc.contributor.author |
Pesantes Villa, María Amalia |
|
dc.contributor.author |
Sacksteder, Katherine A. |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.contributor.author |
Miranda, J. Jaime |
|
dc.date.accessioned |
2020-07-14T00:00:57Z |
|
dc.date.available |
2020-07-14T00:00:57Z |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/8234 |
|
dc.description.abstract |
Replacement of regular salt with potassium-enriched substitutes reduces blood pressure in controlled situations, mainly among people with hypertension. We report on a population-wide implementation of this strategy in a stepped-wedge cluster randomized trial (NCT01960972). The regular salt in enrolled households was retrieved and replaced, free of charge, with a combination of 75% NaCl and 25% KCl. A total of 2,376 participants were enrolled in 6 villages in Tumbes, Peru. The fully adjusted intention-to-treat analysis showed an average reduction of 1.29 mm Hg (95% confidence interval (95% CI) (-2.17, -0.41)) in systolic and 0.76 mm Hg (95% CI (-1.39, -0.13)) in diastolic blood pressure. Among participants without hypertension at baseline, in the time- and cluster-adjusted model, the use of the salt substitute was associated with a 51% (95% CI (29%, 66%)) reduced risk of developing hypertension compared with the control group. In 24-h urine samples, there was no evidence of differences in sodium levels (mean difference 0.01; 95% CI (0.25, -0.23)), but potassium levels were higher at the end of the study than at baseline (mean difference 0.63; 95% CI (0.78, 0.47)). Our results support a case for implementing a pragmatic, population-wide, salt-substitution strategy for reducing blood pressure and hypertension incidence. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Springer Nature |
|
dc.relation.ispartofseries |
Nature Medicine |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Adult |
en_US |
dc.subject |
Female |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
Peru/epidemiology |
en_US |
dc.subject |
Surveys and Questionnaires |
en_US |
dc.subject |
Follow-Up Studies |
en_US |
dc.subject |
Residence Characteristics |
en_US |
dc.subject |
Blood Pressure/drug effects |
en_US |
dc.subject |
Case-Control Studies |
en_US |
dc.subject |
Diastole |
en_US |
dc.subject |
Hypertension/epidemiology/physiopathology/urine |
en_US |
dc.subject |
Incidence |
en_US |
dc.subject |
Potassium/urine |
en_US |
dc.subject |
Sodium Chloride, Dietary/adverse effects |
en_US |
dc.subject |
Sodium/urine |
en_US |
dc.subject |
Systole |
en_US |
dc.title |
Effect of salt substitution on community-wide blood pressure and hypertension incidence |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1038/s41591-020-0754-2 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#1.06.03 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.00.00 |
|
dc.relation.issn |
1546-170X |
|